Michael R. Bishop

862 total citations
21 papers, 628 citations indexed

About

Michael R. Bishop is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Michael R. Bishop has authored 21 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Michael R. Bishop's work include Hematopoietic Stem Cell Transplantation (14 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Neutropenia and Cancer Infections (4 papers). Michael R. Bishop is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Neutropenia and Cancer Infections (4 papers). Michael R. Bishop collaborates with scholars based in United States, France and Malaysia. Michael R. Bishop's co-authors include Anne Kessinger, Stefano Tarantolo, Julie M. Vose, Jamés O. Armitage, Philip J. Bierman, Ž Pavletić, John D. Jackson, Robert B. Geller, James C. Lynch and Mary E. Morris and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Clinical Microbiology.

In The Last Decade

Michael R. Bishop

21 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Bishop United States	14	428	215	149	88	83	21	628
Vaneuza Araújo Moreira Funke Brazil	14	431 1.0×	176 0.8×	108 0.7×	58 0.7×	130 1.6×	61	646
Giuseppe Irrera Italy	18	572 1.3×	337 1.6×	136 0.9×	36 0.4×	94 1.1×	51	828
Axel A. Fauser Germany	15	643 1.5×	264 1.2×	240 1.6×	55 0.6×	103 1.2×	27	978
Michela Cerno Italy	14	372 0.9×	234 1.1×	158 1.1×	110 1.3×	77 0.9×	32	653
Inmaculada Heras Spain	17	494 1.2×	281 1.3×	163 1.1×	48 0.5×	112 1.3×	44	962
K. Quabeck Germany	11	345 0.8×	119 0.6×	174 1.2×	100 1.1×	57 0.7×	35	686
RA Krance United States	10	423 1.0×	119 0.6×	75 0.5×	41 0.5×	64 0.8×	16	636
David Stroncek United States	7	688 1.6×	183 0.9×	349 2.3×	39 0.4×	123 1.5×	15	834
Prentice Hg United Kingdom	14	354 0.8×	177 0.8×	145 1.0×	44 0.5×	68 0.8×	20	622
V Altomonte United States	13	562 1.3×	179 0.8×	302 2.0×	145 1.6×	78 0.9×	15	781

Countries citing papers authored by Michael R. Bishop

Since Specialization

Citations

This map shows the geographic impact of Michael R. Bishop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Bishop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Bishop more than expected).

Fields of papers citing papers by Michael R. Bishop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Bishop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Bishop. The network helps show where Michael R. Bishop may publish in the future.

Co-authorship network of co-authors of Michael R. Bishop

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Bishop. A scholar is included among the top collaborators of Michael R. Bishop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Bishop. Michael R. Bishop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Misra, Maneesh Kumar, Nicholas K. Brown, Michael R. Bishop, et al.. (2019). Effective desensitization for a strong donor‐specific HLA antibody in a case of HLA‐mismatched allogeneic hematopoietic cell transplantation. HLA. 94(3). 307–311. 3 indexed citations

Besien, Koen van, Andrew Artz, Mei‐Jie Zhang, et al.. (2014). Haplo+cord transplantation: Neutrophil and platelet recovery and long-term survival compared to double umbilical cord blood (UCB) transplantation—A case-cohort analysis.. Journal of Clinical Oncology. 32(15_suppl). 7004–7004. 3 indexed citations

Cook, Raymond, Mukta Arora, Hillard M. Lazarus, et al.. (2012). Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis. Bone Marrow Transplantation. 47(11). 1455–1458. 13 indexed citations

Salit, Rachel B., Frances T. Hakim, Michael R. Bishop, et al.. (2012). Influence of Graft Versus-Host Disease Prophylaxis Regimen On T-Cell Repertoire Diversity Following Reduced-Intensity HLA-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation.. Blood. 120(21). 3054–3054. 1 indexed citations

Salit, Rachel B., Steven Z. Pavletic, Daniel H. Fowler, et al.. (2010). Pilot Randomized Trial Comparing the Effects of Alemtuzumab and Cyclosporine Versus Tacrolimus, Methotrexate and Sirolimus on Graft Versus Host Disease Prevention, Engraftment and Immune Reconstitution After Reduced Intensity Unrelated Donor Transplantation.. Blood. 116(21). 1245–1245. 1 indexed citations

Bishop, Michael R.. (2009). Potential use of hematopoietic stem cells after radiation injury. Stem Cells. 15(S1). 305–310. 2 indexed citations

Vasu, Sumithira, Susan F. Leitman, John F. Tisdale, et al.. (2008). Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood. 112(5). 2092–2100. 95 indexed citations

Hardy, Nancy M., Seth M. Steinberg, Michael Krumlauf, et al.. (2005). Development of graft-versus-host disease depends upon establishment of complete donor T cell chimerism after T cell depleted, reduced intensity hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 11(2). 39–39. 1 indexed citations

Pavletic, Steven Z., Lynette M. Smith, Michael R. Bishop, et al.. (2005). Prognostic factors of chronic graft‐versus‐host disease after allogeneic blood stem‐cell transplantation. American Journal of Hematology. 78(4). 265–274. 51 indexed citations

10.

Navolanic, Patrick M., C-H Pui, Richard A. Larson, et al.. (2003). Elitek™–rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002. Leukemia. 17(3). 499–514. 69 indexed citations

11.

Bishop, Michael R., Stefano Tarantolo, Robert B. Geller, et al.. (2000). A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. Blood. 96(1). 80–85. 71 indexed citations

12.

Braren, Victor & Michael R. Bishop. (1998). LAPAROSCOPIC BLADDER AUTOAUGMENTATION IN CHILDREN. Urologic Clinics of North America. 25(3). 533–540. 9 indexed citations

13.

Iwen, Peter C., Mark E. Rupp, Michael R. Bishop, et al.. (1998). Disseminated Aspergillosis Caused by Aspergillus ustus in a Patient Following Allogeneic Peripheral Stem Cell Transplantation. Journal of Clinical Microbiology. 36(12). 3713–3717. 32 indexed citations

14.

Bishop, Michael R., Stefano Tarantolo, John D. Jackson, et al.. (1997). Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.. Journal of Clinical Oncology. 15(4). 1601–1607. 24 indexed citations

15.

Pavletić, Ž, Michael R. Bishop, Stefano Tarantolo, et al.. (1997). Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.. Journal of Clinical Oncology. 15(4). 1608–1616. 98 indexed citations

16.

Bishop, Michael R., John D. Jackson, Kim Schmit-Pokorny, et al.. (1996). Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.. Journal of Clinical Oncology. 14(9). 2521–2526. 17 indexed citations

17.

Bishop, Michael R., P. Jean Henslee‐Downey, J R Anderson, et al.. (1996). Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.. PubMed. 18(4). 747–53. 19 indexed citations

18.

Martín‐Algarra, Salvador, Michael R. Bishop, Stefano Tarantolo, et al.. (1995). Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.. Deposito Adademico Digital Universidad De Navarra (University of Navarra). 23(14). 1503–8. 16 indexed citations

19.

Wu, Andrew, S. K. Joshi, Wing C. Chan, et al.. (1995). Effects ofBCR-ABLAntisense Oligonucleotides (AS-ODN) on Human Chronic Myeloid Leukemic Cells: AS-ODN as Effective Purging Agents. Leukemia & lymphoma. 20(1-2). 67–76. 13 indexed citations

20.

Kessinger, Anne, Michael R. Bishop, John D. Jackson, et al.. (1995). Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.. PubMed. 23(7). 609–12. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact